KPRX

KIORA PHARMACEUTICALS INC
—

Company Information

Company Name
KIORA PHARMACEUTICALS INC
CIK
CIK0001372514
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
KPRX: Nasdaq, KPHMW: OTC
Fiscal Year End
December 31
Owner Organization
03 Life Sciences
SIC
2834
SIC Description
Pharmaceutical Preparations
Ticker
KPRX

SEC filing data through

Insider Sentiment

Last purchase
2024-09-11
Last sale
—
Shares purchased (TTM)
22,291
Shares sold (TTM)
0
Buy ratio (TTM)100.0%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
1,047,009
Shares outstanding
6,177,679
Ownership
16.95%
-6.41% Y/Y

Earnings Market Reaction

Filing date
2026-11-12
Price on filing date
—
1-month reaction
Pending
3-month reaction
Pending
Drift continued3/11 (27%)
Faded / reversed8/11 (73%)

Balance Sheet

Values in millions ($)
Line item2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-31Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value67119614467312
Short Term Investments111038142020232321-0
Prepaid Expense And Other Assets Current111111120000
Accounts Receivable Net Current112212112100
Income Taxes Receivable-----1100222
Assets Current20211922232527303232335
Assets Noncurrent
Property Plant And Equipment Net000000000000
Restricted Cash And Cash Equivalents Noncurrent000000000000
Intangible Assets Net Excluding Goodwill222277777999
Operating Lease Right Of Use Asset000000000000
Other Assets Noncurrent000000000000
Assets222421243032343639414214
Liabilities Current
Accounts Payable Current001100101000
Business Combination Contingent Consideration Liability Current-----------0
Accrued Liabilities Current222223452111
Operating Lease Liability Current000000000000
Liabilities Current323433564222
Liabilities Noncurrent
Business Combination Contingent Consideration Liability Noncurrent333335444555
Deferred Income Tax Liabilities Net000000001111
Contract With Customer Liability Noncurrent111111-0----
Operating Lease Liability Noncurrent000000000000
Liabilities Noncurrent554457555666
Liabilities777871010118888
Stockholders Equity
Preferred Stock Value000000000000
Common Stock Value000000000000
Additional Paid In Capital176176171170170170169169169169168153
Retained Earnings Accumulated Deficit-160-159-157-154-148-148-146-143-139-136-134-147
Accumulated Other Comprehensive Income Loss Net Of Tax-0-0-0-0-0-0-0-0-0-0-0-0
Stockholders Equity15171416222224263033226
Liabilities And Stockholders Equity222421243032343639414214
Series A Preferred Stock-00000000000
Series B Preferred Stock-00000000000
Series C Preferred Stock-00000000000
Series D Preferred Stock-00000000000
Series E Preferred Stock-00000000000
Series F Preferred Stock-00000000000
Preferred Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized101010101010101010101010
Common Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized1501501501501501501501501501505050
Common Stock Shares Issued444433333331
Shares Outstanding444433333331

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

KIORA PHARMACEUTICALS INC (KPRX) — SEC Financial Statements & Analysis

KIORA PHARMACEUTICALS INC (KPRX) is a pharmaceutical preparations company, incorporated in DE. KIORA PHARMACEUTICALS INC trades on Nasdaq, OTC as: KPRX, KPHMW. KIORA PHARMACEUTICALS INC (KPRX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-09-30, filed with the SEC on 2026-11-12. Based on that filing, KIORA PHARMACEUTICALS INC carries a market cap of $16.12M, a P/E ratio of -1.26x, a P/B ratio of 1.05x, a P/S ratio of 634.66x, an enterprise value of $10.54M, and an EV/EBITDA multiple of -0.77x. On profitability, it posts an operating margin of -55210.80%, a net margin of -60257.27%, a Return on Equity (ROE) of -67.70%, a Return on Assets (ROA) of -48.87%, and a Return on Invested Capital (ROIC) of -103.12%. Per share, it reports EPS of $-2.03, diluted EPS of $-2.03, free cash flow per share of $-1.25, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 49.41% year-over-year, and EPS growth of 1.82% year-over-year. On the balance sheet, it maintains a current ratio of 7.91x, a quick ratio of 7.51x, working capital of $17.40M, a debt-to-equity ratio of 0.46x, a debt ratio of 0.32, an interest coverage ratio of -31.78x, free cash flow of $-7.90M (TTM), and net debt of $-5.58M. Figures sourced from SEC EDGAR.

Market Cap
$16.12M
P/E TTM
-1.26x
EPS TTM
$-2.03
P/B TTM
1.05x
ROE TTM
-67.70%
ROA TTM
-48.87%
Debt To Equity
0.46x
Free Cash Flow TTM
$-7.90M
Net Revenue TTM Growth 1Y
-100.00%

Data as of 2026-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is KIORA PHARMACEUTICALS INC in?

KIORA PHARMACEUTICALS INC (KPRX) operates in the Pharmaceutical Preparations industry.

What exchange does KPRX trade on?

KIORA PHARMACEUTICALS INC (KPRX) trades on the Nasdaq, OTC.

Where is KIORA PHARMACEUTICALS INC incorporated?

KIORA PHARMACEUTICALS INC is incorporated in DE.

When was KIORA PHARMACEUTICALS INC (KPRX)'s most recent SEC filing?

KIORA PHARMACEUTICALS INC (KPRX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-09-30, filed with the SEC on 2026-11-12.

What is KPRX's market cap?

KIORA PHARMACEUTICALS INC (KPRX) has a market capitalization of $16.12M as of 2026-09-30.

What is KPRX's EPS (earnings per share)?

KIORA PHARMACEUTICALS INC (KPRX)'s trailing twelve month EPS is $-2.03 as of 2026-09-30.

What is KPRX's ROE (return on equity)?

KIORA PHARMACEUTICALS INC (KPRX)'s trailing twelve month Return on Equity (ROE) is -67.70% as of 2026-09-30.

What is KPRX's ROA (return on assets)?

KIORA PHARMACEUTICALS INC (KPRX)'s trailing twelve month Return on Assets (ROA) is -48.87% as of 2026-09-30.

What is KPRX's ROIC (return on invested capital)?

KIORA PHARMACEUTICALS INC (KPRX)'s trailing twelve month Return on Invested Capital (ROIC) is -103.12% as of 2026-09-30.

What is KPRX's EV/EBITDA?

KIORA PHARMACEUTICALS INC (KPRX)'s trailing twelve month EV/EBITDA is -0.77x as of 2026-09-30.

Wall Street's data.
Main Street's price.